CLINICAL_TRIALS
trial_result
· 2022-11-03
Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140 [Phase 2, Phase 3]
Summary
Clinical trial update for PRO 140 in HIV includes randomized Phase 2/3 data with subsequent single-arm treatment; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CytoDyn, Inc. | Conditions: HIV | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-11-03